BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 9534946)

  • 1. Thymoquinone ameliorates the nephrotoxicity induced by cisplatin in rodents and potentiates its antitumor activity.
    Badary OA; Nagi MN; al-Shabanah OA; al-Sawaf HA; al-Sohaibani MO; al-Bekairi AM
    Can J Physiol Pharmacol; 1997 Dec; 75(12):1356-61. PubMed ID: 9534946
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oral thymoquinone administration ameliorates: the effect of cisplatin on brush border membrane enzymes, energy metabolism, and redox status in rat kidney.
    Farooqui Z; Shahid F; Abidi S; Parwez I; Khan F
    Naunyn Schmiedebergs Arch Pharmacol; 2017 Dec; 390(12):1271-1284. PubMed ID: 28944407
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oral administration of Nigella sativa oil and thymoquinone attenuates long term cisplatin treatment induced toxicity and oxidative damage in rat kidney.
    Farooqui Z; Shahid F; Khan AA; Khan F
    Biomed Pharmacother; 2017 Dec; 96():912-923. PubMed ID: 29223554
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thymoquinone attenuates ifosfamide-induced Fanconi syndrome in rats and enhances its antitumor activity in mice.
    Badary OA
    J Ethnopharmacol; 1999 Nov; 67(2):135-42. PubMed ID: 10619376
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nordihydroguaiaretic acid ameliorates cisplatin induced nephrotoxicity and potentiates its anti-tumor activity in DMBA induced breast cancer in female Sprague-Dawley rats.
    Mundhe NA; Kumar P; Ahmed S; Jamdade V; Mundhe S; Lahkar M
    Int Immunopharmacol; 2015 Sep; 28(1):634-42. PubMed ID: 26247680
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sunitinib improves chemotherapeutic efficacy and ameliorates cisplatin-induced nephrotoxicity in experimental animals.
    Suddek GM
    Cancer Chemother Pharmacol; 2011 May; 67(5):1035-44. PubMed ID: 20652569
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of thymoquinone treatment on the combined renal and pulmonary toxicity of cisplatin and diesel exhaust particles.
    Ali BH; Al Za'abi M; Shalaby A; Manoj P; Waly MI; Yasin J; Fahim M; Nemmar A
    Exp Biol Med (Maywood); 2015 Dec; 240(12):1698-707. PubMed ID: 25925792
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulation of renal organic anion and cation transporters by thymoquinone in cisplatin induced kidney injury.
    Ulu R; Dogukan A; Tuzcu M; Gencoglu H; Ulas M; Ilhan N; Muqbil I; Mohammad RM; Kucuk O; Sahin K
    Food Chem Toxicol; 2012 May; 50(5):1675-9. PubMed ID: 22414646
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thymoquinone supplementation prevents the development of gentamicin-induced acute renal toxicity in rats.
    Sayed-Ahmed MM; Nagi MN
    Clin Exp Pharmacol Physiol; 2007; 34(5-6):399-405. PubMed ID: 17439407
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protective effects of thymoquinone on vancomycin-induced nephrotoxicity in rats.
    Basarslan F; Yilmaz N; Ates S; Ozgur T; Tutanc M; Motor VK; Arica V; Yilmaz C; Inci M; Buyukbas S
    Hum Exp Toxicol; 2012 Jul; 31(7):726-33. PubMed ID: 22318306
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thymoquinone supplementation ameliorates cisplatin-induced hepatic pathophysiology.
    Shahid F; Farooqui Z; Alam T; Abidi S; Parwez I; Khan F
    Hum Exp Toxicol; 2021 Oct; 40(10):1673-1684. PubMed ID: 33832332
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thymoquinone Ameliorates Cadmium-Induced Nephrotoxicity, Apoptosis, and Oxidative Stress in Rats is Based on its Anti-Apoptotic and Anti-Oxidant Properties.
    Erboga M; Kanter M; Aktas C; Sener U; Fidanol Erboga Z; Bozdemir Donmez Y; Gurel A
    Biol Trace Elem Res; 2016 Mar; 170(1):165-72. PubMed ID: 26226832
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oral administration of thymoquinone mitigates the effect of cisplatin on brush border membrane enzymes, energy metabolism and antioxidant system in rat intestine.
    Shahid F; Farooqui Z; Abidi S; Parwez I; Khan F
    Biomed Pharmacother; 2017 Oct; 94():1111-1120. PubMed ID: 28821162
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Loading of doxorubicin and thymoquinone with F2 gel nanofibers improves the antitumor activity and ameliorates doxorubicin-associated nephrotoxicity.
    Zidan AA; El-Ashmawy NE; Khedr EG; Ebeid EM; Salem ML; Mosalam EM
    Life Sci; 2018 Aug; 207():461-470. PubMed ID: 29885348
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oral Nigella sativa oil and thymoquinone administration ameliorates the effect of long-term cisplatin treatment on the enzymes of carbohydrate metabolism, brush border membrane, and antioxidant defense in rat intestine.
    Shahid F; Farooqui Z; Khan AA; Khan F
    Naunyn Schmiedebergs Arch Pharmacol; 2018 Feb; 391(2):145-157. PubMed ID: 29302711
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thymoquinone attenuates Doxorubicin-induced nephrotoxicity in rats: Role of Nrf2 and NOX4.
    Elsherbiny NM; El-Sherbiny M
    Chem Biol Interact; 2014 Nov; 223():102-8. PubMed ID: 25268985
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thymoquinone and curcumin combination protects cisplatin-induced kidney injury, nephrotoxicity by attenuating NFκB, KIM-1 and ameliorating Nrf2/HO-1 signalling.
    Al Fayi M; Otifi H; Alshyarba M; Dera AA; Rajagopalan P
    J Drug Target; 2020 Nov; 28(9):913-922. PubMed ID: 31983246
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The use of thymoquinone in nephrotoxicity related to acetaminophen.
    Aycan İÖ; Tokgöz O; Tüfek A; Alabalık U; Evliyaoğlu O; Turgut H; Çelik F; Güzel A
    Int J Surg; 2015 Jan; 13():33-37. PubMed ID: 25447604
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevention of cisplatin-induced nephrotoxicity by methimazole.
    Osman AM; El-Sayed EM; El-Demerdash E; Al-Hyder A; El-Didi M; Attia AS; Hamada FM
    Pharmacol Res; 2000 Jan; 41(1):115-21. PubMed ID: 10600279
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of nitric oxide synthase aggravates cisplatin-induced nephrotoxicity: effect of 2-amino-4-methylpyridine.
    Saad SY; Najjar TA; Daba MH; Al-Rikabi AC
    Chemotherapy; 2002; 48(6):309-15. PubMed ID: 12673106
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.